NEWS FROM CPHI

Polymers make you go faster, greener, say BASF and Colorcon

By Fiona BARRY

- Last updated on GMT

Paint it, white: Colorcon says the new coating system allows extremely white colour. (Photo: Flickr/Tracie Andrews)
Paint it, white: Colorcon says the new coating system allows extremely white colour. (Photo: Flickr/Tracie Andrews)

Related tags: Polymer

BASF, one of the world’s largest chemical companies, has chosen Colorcon to distribute its Kollicoat Immediate Release (IR) tablet coatings.

Kollicoat uses a “high-productivity polymer system​” – an ethylene glycol and vinyl alcohol graft copolymer – to create a “very white coating with a high finish,​” Colorcon’s David Bain, new MD for the EMEA region, told Outsourcing-Pharma.com.

The instant release allows fast tablet-coating, Bain said, at lower temperatures than previously, “which is excellent from an environmental perspective.​”

While staying green is of less concern to smaller customers, Colorcon’s MD said they would nevertheless be pleased with the platform’s higher productivity.

Collaboration

Under the companies’ combined service model, BASF will continue to sell its polymer technology, but Colorcon will have exclusive global rights to distribute its pill coating formulations to the pharma and nutra industries.

The two firms have previously collaborated on Opadry film-coating systems.

Looking ahead, Bain said the company may consider tweaking the Kollicoat IR technology, “depending on need. Our focus will be evaluating it for faster processing, environmentally-friendl[iness], and colour stability.​”

Kollicoat has been monographed globally and has received GRAS (Generally Regarded As Safe) status in the US.

‘Just ASC’

At CPHI Paris, Colorcon also announced its Just ASC initiative, an annual car maintenance-style check-up with customers to review their products.

The idea is to “simplify their raw materials testing, with the aim to reduce it, and alter lead times​” said Bain, who explained that “scaling up formulae from 5kg to 2 tonnes​” was often the cause of raw material testing delays.

Related news

Show more

Related products

Q2 Solutions: Corporate Brochure

Q2 Solutions: Corporate Brochure

Q2 Solutions | 17-Apr-2020 | Product Brochure

We are an innovative, progressive and responsive partner with the global experience, medical expertise and focus on quality that is integral to drug, medical...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Related suppliers

Follow us

Products

View more

Webinars